|
Surfacine kills microorganisms on contact - but is non-toxic
to mammalian cells.
In laboratory testing, Surfacine treated surfaces effectively
eliminated all human pathogens tested - including bacteria, yeasts
and fungi. Typical testing protocol involves bacterial challenges
of 10^6 CFU/mL (colony forming units per milliliter of saline)
inoculation on treated and untreated control surfaces. After
20 hours in 25C humidity chamber, the surfaces were swabbed and
the live bacteria were counted using the conventional plate counting
method. Control surfaces show bacteria counts of 10^4 to 10^6
CFU/mL while Surfacine treated surfaces
show no measurable level of living microorganisms. We
utilized contract laboratories to perform mold and virus testing
according to standard protocols. To date, Surfacine proved efficacious
against all pathogens tested in this method. The following table
lists all the pathogens tested to date, their ATCC strain number,
type of organism, and the type of efficacy tested:
| Pathogen |
ATCC# |
Type |
Efficacy |
| Escherichia
coli |
8739 |
Gram
negative bacteria |
Sustained |
| Escherichia
coli O157:H7 |
43895 |
Gram
negative bacteria |
Immediate
& sustained |
| Pseudomonas
aeruginosa |
9027 |
Gram
negative bacteria |
Immediate
& sustained |
| Pseudomonas
aeruginosa |
15442 |
Gram
negative bacteria |
Immediate
& sustained |
| Pseudomonas
cepacia |
25416 |
Gram
negative bacteria |
Immediate
& sustained |
| Pseudomonas
diminuta |
19146 |
Gram
negative bacteria |
Immediate
& sustained |
| Klebsiella
pneumoniae |
13883 |
Gram
negative bacteria |
Sustained |
| Serratia
marcescens |
8100 |
Gram
negative bacteria |
Sustained |
| Brevundimonas
diminuta |
19146 |
Gram
negative bacteria |
Sustained |
| Burkholderia
cepacia |
25416 |
Gram
negative bacteria |
Sustained |
| Campylobacter
jejuni |
33560 |
Gram
negative bacteria |
Sustained |
| Escherichia
coli |
11229 |
Gram
negative bacteria |
Immediate
& sustained |
| Escherichia
coli |
10536 |
Gram
negative bacteria |
Immediate
& sustained |
| Escherichia
coli |
11775 |
Gram
negative bacteria |
Sustained |
| Escherichia
coli |
4157 |
Gram
negative bacteria |
Sustained |
| Myroides
odoratus |
4651 |
Gram
negative bacteria |
Sustained |
| Providencia
alcalifaciens |
9886 |
Gram
negative bacteria |
Sustained |
| Shigella
flexneri |
29903 |
Gram
negative bacteria |
Sustained |
| Enterococcus
faecalis |
19433 |
Gram
positive bacteria |
Sustained |
| Streptococcus
mutans |
35668 |
Gram
positive bacteria |
Immediate
& sustained |
| Streptococcus
sanguis |
10556 |
Gram
positive bacteria |
Sustained |
| Staphylococcus
aureus |
6538 |
Gram
positive bacteria |
Immediate
& sustained |
| Methicillin
resistant Staphylococcus aureus |
33592 |
Gram
positive bacteria |
Sustained |
| Staphylococcus
epidermidis |
12228 |
Gram
positive bacteria |
Immediate
& sustained |
| Bacillus
cereus |
11778 |
Gram
positive bacteria |
Sustained |
| Salmonella
choleraesuis |
10708 |
Gram
negative bacteria |
Immediate
& sustained |
| Bacillus
subtilis |
6633 |
Gram
positive bacteria |
Sustained |
| Bacillus
subtilis |
19659 |
Gram
positive bacteria |
Immediate |
| Enterococcus
faecalis (Vancomycin resistant) |
51559 |
Gram
positive bacteria |
Immediate
& sustained |
| Enterococcus
faecium (MDR) |
51559 |
Gram
positive bacteria |
Sustained |
| Listeria
monocytogenes |
19114 |
Gram
positive bacteria |
Sustained |
| Listeria
monocytogenes |
15313 |
Gram
positive bacteria |
Sustained |
| Aspergillus
niger (Example) |
9642 |
Mold |
Sustained |
| Aspergillus
niger (static) (Example) |
6275 |
Mold |
Immediate
& sustained |
| Candida
albicans |
18804 |
Yeast |
Immediate
& sustained |
| Candida
parabsilosis |
20246 |
Yeast |
Immediate
& sustained |
| Saccharomyces
cerevisiae |
834 |
Yeast |
Sustained |
| Trichophyton
mentagrophytes |
9533 |
Mold |
Immediate |
| Hepatitis
A |
VR-1073 |
Virus |
Immediate |
| Candida
albicans |
10231 |
Yeast |
Immediate
& sustained |
| Herpes
Simplex Type 1 |
VR-733 |
Virus |
Immediate |
| Polio
Virus Type 1 |
VR-1000 |
Virus |
Immediate |
| Rhinovirus
Type 1 |
VR-1147 |
Virus |
Immediate |
|